focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

12 Oct 2007 07:30

Amphion Innovations PLC12 October 2007 12 October 2007 Amphion innovations plc Proposed issue of 15,909,077 New Ordinary Shares and notice of Extraordinary General Meeting London and New York, 12 October 2007- Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces its intention to raise approximately £3.5 million (before expenses) by the issue of up to 15,909,077 New Ordinary Shares of 1p each in the capital of the Company (the "New Ordinary Shares") to investors by way of subscription and placing for an issue price of 22 pence per New Ordinary Share (the "Issue Price") to enable the Company to invest in current and new Partner Companies and to provide working capital for the Company. The New Ordinary Shares will represent approximately 14.45 per cent of the Existing Amphion Share Capital. As part of the Issue, the Company has entered into the Subscription Agreementswith several investors who have between them agreed with the Company tosubscribe on a conditional basis for an aggregate of 15,022,727 New OrdinaryShares at the Issue Price raising approximately £3,305,000 (before expenses).This includes a subscription by the Chief Executive, Richard Morgan, for 760,714New Ordinary Shares. Subject to approval at the EGM Richard Morgan will have abeneficial interest in 20,862,327 Ordinary Shares in the Company being 16.55 percent. of the enlarged issued share capital of the Company. As part of theSubscription, MSA, which is 50 per cent. owned by Amphion, has committed tosubscribe £577,823 for 2,626,468 New Ordinary Shares at the Issue Price. TheSubscription Agreements are conditional upon the passing of the SpecialResolution at the Extraordinary General Meeting and Admission. In addition to the subscription agreements, Charles Stanley has conditionallyagreed pursuant to the Placing Agreement to place 886,350 New Ordinary Shares atthe Issue Price, raising approximately £195,000 (before expenses). CharlesStanley's obligations under the Placing Agreement are conditional, inter alia,upon the passing of the Special Resolution at the Extraordinary General Meetingand Admission. As a result of the above, and to enable the Company to implement the Issue on anon-pre-emptive basis, it is necessary for the Company to approve the Issuebeing made otherwise than in accordance with the Pre-emption Provisions by wayof a special resolution at an Extraordinary General Meeting. Subject to approval at the EGM the enlarged number of shares in issue will beapproximately 126,019,301 Ordinary Shares. Further Issues The Company has to date granted options to employees and Directors under theShare Option Scheme in respect of 125,000 Ordinary Shares. The Company is nowproposing to grant options in respect of a further 7,750,000 Ordinary Shares atan issue price of 23 pence per Ordinary Share to certain employees and Directorsunder the terms of the Share Option Scheme. This will include options in respectof 2,000,000 Ordinary Shares granted to Richard Morgan and in respect of1,250,000 Ordinary Shares granted to Robert Bertoldi. Authority for theallotment of Ordinary Shares under the Share Option Scheme has already beengiven by the Shareholders in general meeting. In addition, the Company wishes to have some flexibility to permit furtherissues of Ordinary Shares for cash otherwise than in accordance with thePre-emption Provisions and also to be able to grant options to service providersto the Company in consideration for services provided to the Company. Suchoptions are not granted to employees or Directors and, accordingly, fall outsidethe Share Option Scheme. In order to ensure that the Pre-emption Provisions do not apply to such furtherissues of Ordinary Shares for cash or to the allotment of any Ordinary Sharesfor cash following the exercise of options granted to such service providers,authority is now being sought for the allotment for cash of a further 12,600,000Ordinary Shares (representing approximately 10 per cent. of the Ordinary Sharesin issue immediately following the Issue) (the "Additional Shares"), otherwisethan in accordance with the Pre-emption Provisions, in the Special Resolution atthe Extraordinary General Meeting. Extraordinary General Meeting A circular to shareholders containing a notice of Extraordinary General Meetingof the Company is to be held on 5 November 2007 at Amphion's offices at OneBerkeley Street, London W1J 8DJ at 11.00 a.m. at which the Special Resolutionwill be proposed and voted upon for the purposes of facilitating the Issue ofNew Ordinary Shares. The Special Resolution will, if passed, disapply the Pre-emption Provisionscontained in Article 5.1 of the Articles in relation to the issue of the NewOrdinary Shares pursuant to the Issue and, in addition to the the allotment ofthe Additional Shares. It is expected that admission of the New Ordinary Shares to trading on AIM willbecome effective and dealings, for normal settlement, will commence on 6November 2007. The New Ordinary Shares will be eligible for settlement throughCREST. Whether or not they propose to attend the Extraordinary General Meeting, AmphionShareholders are requested to complete and sign the Form of Proxy and return itby post or (during normal business hours) by hand to Amphion's registered officeat 15-19 Athol Street, Douglas, Isle of Man IM1 1LB as soon as possible and, inany event, so as to arrive no later than 48 hours before the time of theExtraordinary General Meeting. Further information is contained in the Circularto Shareholder dated 12 October 2007. The Board considers that the proposals asset out in the Circular are in the best interests of the Company and theShareholders as a whole. Accordingly, the Board unanimously recommends allShareholders to vote in favour of the Special Resolution at the forthcomingExtraordinary General Meeting as they have irrevocably undertaken to do inrespect of the 48,771,122 Ordinary Shares registered in their own names(representing approximately 44.29 per cent. of the Existing Amphion ShareCapital). Amphion's Chief Executive Officer, Richard C.E. Morgan, said: "As we said in our interim statement in September, Amphion has had a promisingfirst half of the year, reporting a 35.7per cent. rise in net asset value pershare and 48 per cent. increase in the fair value of our portfolio. These newfunds raised will enable us to continue this strong progress within our currentPartner Companies and also allow us to seek new opportunities where we feelthere is significant opportunity for growth and shareholder return." For further information, please contact: Amphion Innovations plc +1 212 210 6224Charlie Morgan Financial Dynamics +44 20 7831 3113Ben AtwellJohn Gilbert Charles Stanley Securities (Nominated Adviser) +44 20 7149 6000Mark Taylor / Freddy Crossley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jul 20155:07 pmRNSHolding(s) in Company
23rd Jun 20158:47 amRNSPartner Company raises £22 million
23rd Jun 20157:00 amRNSPreliminary Results
5th Jun 20157:00 amRNSPlacing to raise £1.54 million
19th May 20152:35 pmRNSAppointment of broker
15th Apr 20157:01 amRNSFDA Results
7th Apr 20157:00 amRNSShares Issued for Exercised Warrants
2nd Apr 20157:01 amRNSFirst Day of Dealings of Amphion Partner Company
24th Mar 20153:28 pmRNSIssue of Shares
20th Mar 20157:01 amRNSMotif Bio Ltd Update Re Intention to Float
26th Feb 20157:00 amRNSIssue of Equity
9th Feb 20157:00 amRNSDirector/PDMR Shareholding
2nd Feb 20154:18 pmRNSReissue: Partner Company's Intention to Float
2nd Feb 20158:00 amRNSPartner Company's Intention to Float on AIM
22nd Jan 20151:15 pmRNSDirector/PDMR Shareholding
19th Jan 20157:00 amRNSLandmark Acquisition & Update by Partner Company
6th Jan 20157:00 amRNSDataTern Receives Favourable Appeal Ruling
24th Sep 20147:00 amRNSDirectors' Dealings
19th Sep 20147:00 amRNSHalf Yearly Report
9th Sep 20147:00 amRNSAdditional Draws on Loan Facility
28th Aug 20147:00 amRNSDirectorate Change
7th Aug 20144:51 pmRNSResult of AGM and EGM
10th Jul 20149:10 amRNSDirectors' Dealings
8th Jul 20147:00 amRNSAmphion Partner Motif Can Help Solve Health Crisis
20th Jun 20147:00 amRNSNotice of EGM
18th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSNew Loan Facility
14th Apr 20147:00 amRNSAppeal Ruling
7th Apr 20145:03 pmRNSDirector/PDMR Shareholding
28th Jan 20147:00 amRNSConvertible Promissory Note Extension
12th Dec 20137:00 amRNSUpdate on Covertible Promissory Note
13th Nov 20134:33 pmRNSDirector/PDMR Shareholding
13th Nov 20137:00 amRNSPartner Company Update
16th Oct 20137:02 amRNSPartner Company IPO
24th Sep 20137:00 amRNSHalf Yearly Report
12th Sep 20137:02 amRNSPartner company Kromek seeks IPO on AIM
13th Aug 20135:16 pmRNSResult of AGM
1st Jul 201312:02 pmRNSDirector/PDMR Shareholding
28th Jun 20137:00 amRNSFinal Results
18th Apr 20137:00 amRNSDirector/PDMR Shareholding
17th Apr 20137:00 amRNSTrading Statement
28th Mar 20137:02 amRNSChange of Adviser
19th Dec 20127:00 amRNSHolding(s) in Company
13th Dec 20127:00 amRNSFundraising
5th Dec 20127:00 amRNSAmphion announces new partnership with Motif
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
28th Sep 20124:24 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSHalf Yearly Report
29th Aug 20127:00 amRNSUpdate - patent litigation
27th Jul 20127:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.